{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:10:45Z","timestamp":1794564645645,"version":"4.9.1"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:p>Malignant mesothelioma can be difficult to distinguish from other malignancies, particularly non\u2013small cell lung carcinomas (NSCLCs), without immunohistochemistry. However, conventional markers of mesothelial lineage all have variable degrees of cross-reactivity with other neoplasms, including NSCLCs, necessitating the use of multiple mesothelioma and carcinoma markers in every case for accurate diagnosis. A recently described monoclonal HEG homolog 1 (HEG1) antibody was proposed to be a specific marker for mesothelioma. Here we performed a large scale assessment of the SKM9-2 HEG1 antibody using tissue microarrays containing 69 epithelioid mesotheliomas, 32 sarcomatoid mesotheliomas, 167 NSCLCs, and 17 ovarian high-grade serous carcinomas. Strong membrane staining, usually diffuse, for HEG1 was seen in 65\/69 (94%) epithelioid mesotheliomas, 0\/60 pulmonary squamous cell carcinomas, 0\/73 pulmonary adenocarcinomas, and 0\/13 pulmonary large cell carcinomas. HEG1 showed staining in 14\/32 (44%) sarcomatoid mesotheliomas compared with 0\/21 sarcomatoid pulmonary carcinomas. Three of 17 (18%) high-grade serous carcinomas demonstrated membrane staining. Ten B3 thymoma whole sections were negative. On the microarrays, the conventional mesothelial markers calretinin, WT1, D2-40, and CK5\/6 had sensitivities for epithelioid mesothelioma of 94%, 90%, 96%, and 91%, respectively. We conclude that HEG1 SKM9-2 antibody offers sensitivity comparable to conventional markers for epithelioid mesotheliomas, but provides considerably better specificity, such that the diagnosis of epithelioid mesothelioma versus NSCLC potentially could be confirmed with a combination of HEG1 and a suitable broad spectrum carcinoma marker such as claudin-4. HEG1 is specific but insensitive for separating sarcomatoid mesotheliomas from sarcomatoid lung carcinomas.<\/jats:p>","DOI":"10.1097\/pas.0000000000001469","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T23:31:56Z","timestamp":1584574316000},"page":"1143-1148","source":"Crossref","is-referenced-by-count":41,"title":["HEG1 Is a Highly Specific and Sensitive Marker of Epithelioid Malignant Mesothelioma"],"prefix":"10.1097","volume":"44","author":[{"given":"Julia R.","family":"Naso","sequence":"first","affiliation":[{"name":"Department of Pathology, Vancouver General Hospital"},{"name":"Department of Pathology, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoutaro","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Molecular Diagnostics Project, Kanagawa Cancer Center Research Institute, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Churg","sequence":"additional","affiliation":[{"name":"Department of Pathology, Vancouver General Hospital"},{"name":"Department of Pathology, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,3,19]]},"reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/PAI.0b013e31829b6fbd","article-title":"Value of calretinin immunostaining in diagnostic pathology: a review and update","volume":"22","author":"Ord\u00f3\u00f1ez","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"45768","DOI":"10.1038\/srep45768","article-title":"HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma","volume":"7","author":"Tsuji","year":"2017","journal-title":"Sci Rep"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"14251","DOI":"10.1038\/s41598-018-32534-8","article-title":"Identification of mesothelioma-specific sialylated epitope recognized with monoclonal antibody SKM9-2 in a mucin-like membrane protein HEG1","volume":"8","author":"Matsuura","year":"2018","journal-title":"Sci Rep"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"e28939","DOI":"10.7554\/eLife.28939","article-title":"Heg1 and Ccm1\/2 proteins control endocardial mechanosensitivity during zebrafish valvulogenesis","volume":"7","author":"Donat","year":"2018","journal-title":"Elife"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nm.1918","article-title":"Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway","volume":"15","author":"Kleaveland","year":"2009","journal-title":"Nat Med"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1042\/CS20190704","article-title":"A novel function for HEG1 in promoting metastasis in hepatocellular carcinoma","volume":"133","author":"Dewdney","year":"2019","journal-title":"Clin Sci"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1042\/CS20190225","article-title":"HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt\/\u03b2-catenin signaling","volume":"133","author":"Zhao","year":"2019","journal-title":"Clin Sci"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lungcan.2018.11.032","article-title":"Molecular pathways and diagnosis in malignant mesothelioma: a review of the 14th International Conference of the International Mesothelioma Interest Group","volume":"127","author":"Chapel","year":"2019","journal-title":"Lung Cancer"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/modpathol.3800544","article-title":"The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study","volume":"19","author":"Ord\u00f3\u00f1ez","year":"2006","journal-title":"Mod Pathol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/modpathol.3800259","article-title":"Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma","volume":"18","author":"Chu","year":"2005","journal-title":"Mod Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.humpath.2012.11.016","article-title":"Broad-spectrum immunohistochemical epithelial markers: a review","volume":"44","author":"Ord\u00f3\u00f1ez","year":"2013","journal-title":"Hum Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001469","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T23:03:44Z","timestamp":1695423824000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,19]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001469","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,19]]}}}